Harvard Bioscience, Inc.
HBIO
$0.3587
-$0.0119-3.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.34% | -4.09% | -14.44% | -6.38% | 12.30% |
| Total Receivables | -11.95% | -7.66% | -14.36% | -26.13% | -13.69% |
| Inventory | -5.47% | -5.95% | 0.67% | -3.68% | -10.14% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -31.18% | -26.45% | -21.73% | -10.09% | 9.50% |
| Total Current Assets | -6.74% | -8.00% | -7.32% | -11.76% | -8.20% |
|
|
|||||
| Total Current Assets | -6.74% | -8.00% | -7.32% | -11.76% | -8.20% |
| Net Property, Plant & Equipment | 38.88% | 28.38% | 39.49% | 4.96% | -0.87% |
| Long-term Investments | -84.20% | -1.30% | 2.16% | -0.25% | 0.14% |
| Goodwill | -84.20% | -1.30% | 2.16% | -0.25% | 0.14% |
| Total Other Intangibles | -30.99% | -30.58% | -27.81% | -26.78% | -25.27% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.00% | -4.71% | -61.08% | -50.05% | -61.15% |
| Total Assets | -40.07% | -7.81% | -6.08% | -9.79% | -8.53% |
|
|
|||||
| Total Accounts Payable | -20.45% | -13.81% | -15.73% | 21.10% | 1.10% |
| Total Accrued Expenses | -29.18% | -48.98% | -31.27% | -36.61% | -0.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 660.16% | 423.90% | -15.41% | -10.61% | -3.59% |
| Total Finance Division Other Current Liabilities | -1.91% | 5.53% | 19.55% | 9.88% | 30.86% |
| Total Other Current Liabilities | -1.91% | 5.53% | 19.55% | 9.88% | 30.86% |
| Total Current Liabilities | 116.55% | 107.06% | -6.01% | -1.40% | 10.60% |
|
|
|||||
| Total Current Liabilities | 116.55% | 107.06% | -6.01% | -1.40% | 10.60% |
| Long-Term Debt | -- | -- | -2.26% | -16.34% | -23.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 58.66% | 33.10% | 51.79% | 1.29% | -7.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.13% | -4.29% | 27.82% | 38.41% | 42.63% |
| Total Liabilities | 0.96% | -1.54% | 0.72% | -8.66% | -9.67% |
|
|
|||||
| Common Stock & APIC | 1.57% | 1.78% | 1.31% | 1.44% | 1.44% |
| Retained Earnings | -38.62% | -8.52% | -9.90% | -7.49% | -6.17% |
| Treasury Stock & Other | 2.80% | -10.43% | 14.54% | -5.79% | -0.81% |
| Total Common Equity | -78.44% | -13.32% | -12.07% | -10.80% | -7.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -78.44% | -13.32% | -12.07% | -10.80% | -7.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -78.44% | -13.32% | -12.07% | -10.80% | -7.44% |
|
|
|||||